Feverfew (Tanacetum parthenium) is the daisy-like garden herb whose parthenolide content has been validated in randomized clinical trials for migraine prevention — a condition that disproportionately affects Black women, who are 40% more likely to experience migraines than white women yet are significantly less likely to receive adequate diagnosis and treatment. The parthenolide in feverfew inhibits platelet serotonin release and prostaglandin synthesis through mechanisms that address the vascular-inflammatory pathway of migraine at a molecular level.
Feverfew grows easily in Southern gardens as a perennial (Zone 5+) — small white daisy flowers, strongly aromatic leaves. Available as supplements at health food stores and pharmacies. For Black women with migraines who cannot access neurological care, feverfew provides a validated evidence-based preventive at less than $15/month cost.
Parthenolide is feverfew's primary bioactive sesquiterpene lactone — it inhibits platelet serotonin release and thromboxane A2 synthesis, addressing the vasoconstriction-vasodilation cycle that triggers classical migraine. A landmark 1988 Lancet randomized controlled trial (72 migraine patients) found feverfew (82mg dried leaf daily) reduced migraine frequency by 24% compared to placebo (p<0.02) and reduced migraine severity. A 2004 Cochrane Review of 5 RCTs found feverfew was more effective than placebo for migraine prevention. Parthenolide also covalently alkylates NF-kB p65 subunit cysteine 38, blocking transcriptional activation — potent anti-inflammatory mechanism at the gene-expression level rather than enzyme inhibition. Luteolin and apigenin provide 5-LOX inhibition, blocking leukotriene B4 production. Cancer research note: parthenolide selectively induces apoptosis in leukemia stem cells (Blood journal, 2005) while sparing normal hematopoietic stem cells — an active area of anti-cancer research. Black American relevance: migraine is massively underdiagnosed and undertreated in Black women, often dismissed by providers as stress headaches. Feverfew provides a validated preventive tool outside the pharmaceutical encounter.
Fresh leaves: 2-3 fresh leaves eaten daily with food (in a sandwich, with yogurt — the fresh leaf is the most bioavailable form). Dried leaf capsules: 50-125mg daily standardized to minimum 0.2% parthenolide. Tincture: 2-3 ml daily. MUST be used as a preventive (daily), not as an acute migraine treatment — parthenolide accumulates to achieve its platelet-modulating effect over 3-4 months.
Free, no account needed to ask.